Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer.
Acta Oncol. 2011 Jan;50(1):35-41. doi: 10.3109/0284186X.2010.535847.
Acta Oncol. 2011.
PMID: 21174610
Clinical Trial.
A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin) on a named patient basis in Sweden.
Andersson J, Linderholm B, Greim G, Lindh B, Lindman H, Tennvall J, Tennvall-Nittby L, Pettersson-Sköld D, Sverrisdottir A, Söderberg M, Klaar S, Bergh J.
Andersson J, et al. Among authors: pettersson skold d.
Acta Oncol. 2002;41(3):276-81. doi: 10.1080/02841860260088827.
Acta Oncol. 2002.
PMID: 12195747
Item in Clipboard
Cite
Cite